-
公开(公告)号：US11426514B2
公开(公告)日：2022-08-30
申请号：US16565013
申请日：2019-09-09
Applicant: Medtronic, Inc.
Inventor： Keith A. Miesel , James M. Haase , Chris J. Paidosh , Darren A. Janzig , Timothy J. Denison
Abstract: The disclosure is directed to a pressure sensor of an implantable medical device. The pressure sensor may utilize detect fluid pressure based on a changing capacitance between two capacitive elements. The pressure sensor may define at least a portion of a fluid enclosure of the IMD. In one example, the pressure sensor has a self-aligning housing shape that occludes an opening in the pump bulkhead of the IMD. An operative surface of the pressure and the portion of the fluid enclosure may be formed of a corrosion resistant and/or biocompatible material. A first capacitive element of the pressure sensor may be a metal alloy diaphragm that deflects in response to external fluid pressure. A second capacitive element of the pressure sensor may be a metal coating on a rigid insulator sealed from the fluid by the diaphragm and a housing of the sensor.
-
公开(公告)号：US11096591B2
公开(公告)日：2021-08-24
申请号：US16365731
申请日：2019-03-27
Applicant: Medtronic, Inc.
Inventor： Keith A. Miesel , Kenneth T. Heruth , Jonathan C. Werder , Steve R. LaPorte , Nina M. Graves
IPC: A61N1/36 , A61M5/172 , A61B5/00 , A61B5/11 , A61M5/142 , A61B5/0205 , A61B3/113 , A61B5/08 , A61B5/145 , A61N1/365 , A61N1/372 , A61B5/369
Abstract: A device determines values for one or more metrics that indicate the quality of a patient's sleep based on sensed physiological parameter values. Sleep efficiency, sleep latency, and time spent in deeper sleep states are example sleep quality metrics for which values may be determined. The sleep quality metric values may be used, for example, to evaluate the effectiveness of a therapy delivered to the patient by a medical device. In some embodiments, determined sleep quality metric values are automatically associated with the therapy parameter sets according to which the medical device delivered the therapy when the physiological parameter values were sensed, and used to evaluate the effectiveness of the various therapy parameter sets. The medical device may deliver the therapy to treat a non-respiratory neurological disorder, such as epilepsy, a movement disorder, or a psychological disorder. The therapy may be, for example, deep brain stimulation (DBS) therapy.
-
公开(公告)号：US10071197B2
公开(公告)日：2018-09-11
申请号：US15646755
申请日：2017-07-11
Applicant: Medtronic, Inc.
Inventor： Dennis M. Skelton , Jon P. Davis , Keith A. Miesel , Timothy J. Denison
CPC classification number: A61M5/14276 , A61B5/11 , A61B5/1116 , A61B5/4836 , A61B2562/0219 , A61M2005/14208 , A61M2205/17 , A61M2210/0693 , A61M2210/1053 , A61M2210/1078 , A61M2210/1089 , A61M2230/62 , A61N1/3605 , A61N1/37247
Abstract: Posture-responsive therapy is delivered by the medical system based on posture state input from only one of multiple posture sensors at any given time. An example implantable medical system includes a first posture sensor and a second sensor. A processor controls therapy delivery to the patient based on at least one of a patient posture state or a patient activity level determined based on input from only one of the first or second posture sensors. In some examples, one of multiple posture sensors of an implantable posture-responsive medical system is used to automatically reorient another posture sensor (of the system), which has become disoriented. The disoriented posture sensor may be automatically reoriented for one or more posture states at a time.
-
公开(公告)号：US09724511B2
公开(公告)日：2017-08-08
申请号：US15256369
申请日：2016-09-02
Applicant: Medtronic, Inc.
Inventor： Xuan K. Wei , Eric H. Bonde , Keith A. Miesel , Mark S. Lent , Gregory F. Molnar
CPC classification number: A61N1/36007 , A61N1/0514 , A61N1/0551 , A61N1/36128 , A61N1/36135 , A61N1/37235 , A61N1/37252
Abstract: Techniques for managing urinary or fecal incontinence include delivering a first type of therapy to generate a first physiological response and, upon detecting a trigger event, delivering a second type of therapy to generate a second physiological response. The first type of therapy can be delivered on a substantially regular basis, while the second type of therapy is delivered as needed to provide an additional boost of therapy. The trigger event for activating the delivery of the second type of therapy may include input from a sensor that indicates a bladder condition, patient activity level or patient posture, or patient input. In some examples, the therapy is stimulation therapy.
-
公开(公告)号：US20160030741A1
公开(公告)日：2016-02-04
申请号：US14880066
申请日：2015-10-09
Applicant: Medtronic, Inc.
Inventor： Xuan K. Wei , Eric H. Bonde , Keith A. Miesel , Mark S. Lent , Gregory F. Molnar
CPC classification number: A61N1/36007 , A61N1/0514 , A61N1/0551 , A61N1/36128 , A61N1/36135 , A61N1/37235 , A61N1/37252
Abstract: Techniques for managing urinary or fecal incontinence include delivering a first type of therapy to generate a first physiological response and, upon detecting a trigger event, delivering a second type of therapy to generate a second physiological response. The first type of therapy can be delivered on a substantially regular basis, while the second type of therapy is delivered as needed to provide an additional boost of therapy. The trigger event for activating the delivery of the second type of therapy may include input from a sensor that indicates a bladder condition, patient activity level or patient posture, or patient input. In some examples, the therapy is stimulation therapy.
-
Patent Agency Ranking
公开(公告)号：US10406281B2
公开(公告)日：2019-09-10
申请号：US15681957
申请日：2017-08-21
Applicant: Medtronic, Inc.
Inventor： Keith A. Miesel , James M. Haase , Chris J. Paidosh , Darren A. Janzig , Timothy J. Denison
Abstract: The disclosure is directed to a pressure sensor of an implantable medical device. The pressure sensor may utilize detect fluid pressure based on a changing capacitance between two capacitive elements. The pressure sensor may define at least a portion of a fluid enclosure of the IMD. In one example, the pressure sensor has a self-aligning housing shape that occludes an opening in the pump bulkhead of the IMD. An operative surface of the pressure and the portion of the fluid enclosure may be formed of a corrosion resistant and/or biocompatible material. A first capacitive element of the pressure sensor may be a metal alloy diaphragm that deflects in response to external fluid pressure. A second capacitive element of the pressure sensor may be a metal coating on a rigid insulator sealed from the fluid by the diaphragm and a housing of the sensor.
-
公开(公告)号：US20190217098A1
公开(公告)日：2019-07-18
申请号：US16365731
申请日：2019-03-27
Applicant: Medtronic, Inc.
Inventor： Keith A. Miesel , Kenneth T. Heruth , Jonathan C. Werder , Steve R. LaPorte , Nina M. Graves
CPC classification number: A61N1/36135 , A61B3/113 , A61B5/0031 , A61B5/0205 , A61B5/0476 , A61B5/0816 , A61B5/1116 , A61B5/1118 , A61B5/145 , A61B5/4815 , A61B5/4818 , A61B5/6814 , A61B5/6823 , A61B5/6825 , A61B5/686 , A61B2562/0219 , A61M5/14276 , A61M5/1723 , A61N1/36025 , A61N1/36064 , A61N1/36067 , A61N1/36071 , A61N1/36082 , A61N1/36521 , A61N1/36542 , A61N1/36557 , A61N1/37247
Abstract: A device determines values for one or more metrics that indicate the quality of a patient's sleep based on sensed physiological parameter values. Sleep efficiency, sleep latency, and time spent in deeper sleep states are example sleep quality metrics for which values may be determined. The sleep quality metric values may be used, for example, to evaluate the effectiveness of a therapy delivered to the patient by a medical device. In some embodiments, determined sleep quality metric values are automatically associated with the therapy parameter sets according to which the medical device delivered the therapy when the physiological parameter values were sensed, and used to evaluate the effectiveness of the various therapy parameter sets. The medical device may deliver the therapy to treat a non-respiratory neurological disorder, such as epilepsy, a movement disorder, or a psychological disorder. The therapy may be, for example, deep brain stimulation (DBS) therapy.
-
公开(公告)号：US20170304534A1
公开(公告)日：2017-10-26
申请号：US15646755
申请日：2017-07-11
Applicant: Medtronic, Inc.
Inventor： Dennis M. Skelton , Jon P. Davis , Keith A. Miesel , Timothy J. Denison
CPC classification number: A61M5/14276 , A61B5/11 , A61B5/1116 , A61B5/4836 , A61B2562/0219 , A61M2005/14208 , A61M2205/17 , A61M2210/0693 , A61M2210/1053 , A61M2210/1078 , A61M2210/1089 , A61M2230/62 , A61N1/3605 , A61N1/37247
Abstract: Posture-responsive therapy is delivered by the medical system based on posture state input from only one of multiple posture sensors at any given time. An example implantable medical system includes a first posture sensor and a second sensor. A processor controls therapy delivery to the patient based on at least one of a patient posture state or a patient activity level determined based on input from only one of the first or second posture sensors. In some examples, one of multiple posture sensors of an implantable posture-responsive medical system is used to automatically reorient another posture sensor (of the system), which has become disoriented. The disoriented posture sensor may be automatically reoriented for one or more posture states at a time.
-
公开(公告)号：US20170156663A1
公开(公告)日：2017-06-08
申请号：US15439152
申请日：2017-02-22
Applicant: Medtronic, Inc.
Inventor： Kenneth T. Heruth , Keith A. Miesel , Gregory F. Molnar
CPC classification number: A61B5/4836 , A61B5/0022 , A61B5/0031 , A61B5/031 , A61B5/0488 , A61B5/1038 , A61B5/112 , A61B5/1123 , A61B5/4082 , A61B5/4094 , A61B5/7246 , A61B5/7275 , A61B5/7282 , A61B5/7405 , A61B5/742 , A61B5/7455 , A61B2562/0219 , A61M5/1723 , A61N1/36003 , A61N1/36067 , A61N1/36082 , A61N1/3615 , G06F19/00
Abstract: A medical device delivers a therapy to a patient. The medical device or another device may periodically determine an activity level or gait parameter of the patient, and associate each determined level or parameter with a current therapy parameter set. A value of at least one activity metric is determined for each of a plurality of therapy parameter sets based on the activity levels or parameters associated with that therapy parameter set. Whether the patient is currently experiencing or anticipated to experience gait freeze caused by their neurological disorder, such as Parkinson's disease, may also be determined. Gait freeze events may be associated with current therapy parameters and used to determine activity metric values. In some examples, the activity metric associated with certain therapy parameters may be presented to a user.
-
公开(公告)号：US20160074600A1
公开(公告)日：2016-03-17
申请号：US14860198
申请日：2015-09-21
Applicant: Medtronic, Inc.
Inventor： Keith A. Miesel
IPC: A61M5/50
CPC classification number: A61M5/5086 , A61M5/14276 , A61M5/16854 , A61M5/16859 , A61M27/006 , A61M2005/1726 , A61M2202/0464
Abstract: A method for determining the status of a catheter of an implanted infusion system, where the catheter is intended to deliver a fluid composition to CSF of a patient, includes monitoring catheter pressure, developing a pressure modulation profile based on the monitored pressure, and comparing the developed pressure modulation profile to a predetermined pressure profile. The predetermined pressure profile may be a profile of cerebrospinal fluid or a bolus infusion or withdrawal profile for the catheter. A determination of catheter status, such as properly functioning, occluded or leaky, can be made based on the comparison.
Abstract translation: 一种用于确定植入式输注系统的导管的状态的方法，其中导管旨在将流体组合物递送到患者的CSF，包括监测导管压力，基于所监测的压力开发压力调节曲线，并将 产生压力调节曲线到预定的压力分布图。 预定的压力分布可以是脑脊液的曲线或导管的推注输注或抽出轮廓。 可以基于比较来确定导管状态，例如正常功能，闭塞或泄漏。
-
-
-
-
-
-
-
-
-
Search Results
33
records
(took 0.035 seconds)
